IDO1 and non-small cell lung carcinoma: Wang and colleagues (59) further demonstrated that in patients with early-stage NSCLC, stereotactic body radiotherapy exerts a less immunosuppressive effect compared with three-dimensional conformal radiotherapy, as evidenced by lower IDO expression.